Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?Juan Luis Steegmann, Santiago Osorio, Vicente Escudero‐Vilaplana et al.|Annals of Hematology|2018Cited by 26
Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based RegistryVerena Hoffmann, Rüediger Hehlmann, Paul Costeas et al.|Blood|2015Cited by 1
Safety and Efficacy of Dasatinib Treatment Change for Patients Previosly Treated with Imatinib with Late Warning Response. Results from the Phase II, Open, Multicenter Dasapost StudyValentín García‐Gutiérrez, Juan Luis Steegmann, Felipe Casado et al.|Blood|2016Cited by 1
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registryAna Alfonso Piérola, David Martínez‐Cuadrón, Rebeca Rodríguez‐Veiga et al.|Leukemia|2025Cited by 1